These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. Bays HE; Toth PP; Kris-Etherton PM; Abate N; Aronne LJ; Brown WV; Gonzalez-Campoy JM; Jones SR; Kumar R; La Forge R; Samuel VT J Clin Lipidol; 2013; 7(4):304-83. PubMed ID: 23890517 [TBL] [Abstract][Full Text] [Related]
8. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. Luna-Luna M; Medina-Urrutia A; Vargas-Alarcón G; Coss-Rovirosa F; Vargas-Barrón J; Pérez-Méndez Ó Arch Med Res; 2015 Jul; 46(5):392-407. PubMed ID: 26009250 [TBL] [Abstract][Full Text] [Related]
9. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome. Wittwer J; Bradley D Front Immunol; 2021; 12():612496. PubMed ID: 33717095 [TBL] [Abstract][Full Text] [Related]
10. Overweight and obesity: the pathogenesis of cardiometabolic risk. Bray GA; Clearfield MB; Fintel DJ; Nelinson DS Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062 [TBL] [Abstract][Full Text] [Related]
11. Impact of Different Adipose Depots on Cardiovascular Disease. Diaz-Canestro C; Xu A J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S30-S39. PubMed ID: 34840259 [TBL] [Abstract][Full Text] [Related]
12. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Piché ME; Poirier P; Lemieux I; Després JP Prog Cardiovasc Dis; 2018; 61(2):103-113. PubMed ID: 29964067 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995 [TBL] [Abstract][Full Text] [Related]
14. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Christensen RH; von Scholten BJ; Hansen CS; Heywood SE; Rosenmeier JB; Andersen UB; Hovind P; Reinhard H; Parving HH; Pedersen BK; Jørgensen ME; Jacobsen PK; Rossing P Eur J Prev Cardiol; 2017 Sep; 24(14):1517-1524. PubMed ID: 28650207 [TBL] [Abstract][Full Text] [Related]
15. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment. Schinzari F; Tesauro M; Cardillo C J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700 [TBL] [Abstract][Full Text] [Related]
16. Cellular Mechanisms Driving Sex Differences in Adipose Tissue Biology and Body Shape in Humans and Mouse Models. Karastergiou K; Fried SK Adv Exp Med Biol; 2017; 1043():29-51. PubMed ID: 29224089 [TBL] [Abstract][Full Text] [Related]
17. Metabolic obesity: the paradox between visceral and subcutaneous fat. Hamdy O; Porramatikul S; Al-Ozairi E Curr Diabetes Rev; 2006 Nov; 2(4):367-73. PubMed ID: 18220642 [TBL] [Abstract][Full Text] [Related]
18. Fat and Cardiometabolic Risk Burden. Purnamasari D Acta Med Indones; 2017 Apr; 49(2):89-90. PubMed ID: 28790221 [No Abstract] [Full Text] [Related]
19. Epicardial adipose tissue and idiopathic deep venous thrombosis: an association study. Mazzoccoli G; Copetti M; Dagostino MP; Grilli M; Fontana A; Pellegrini F; Greco A Atherosclerosis; 2012 Aug; 223(2):378-83. PubMed ID: 22748278 [TBL] [Abstract][Full Text] [Related]
20. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Laforest S; Labrecque J; Michaud A; Cianflone K; Tchernof A Crit Rev Clin Lab Sci; 2015; 52(6):301-13. PubMed ID: 26292076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]